Effect of adjunctive treatment with tirofiban on troponin T elevation during stenting of critically stenosed aortocoronary saphenous vein grafts

被引：6

作者：

Kurowski, V

Toelg, R

Jain, D

Richter, C

Wiegand, UKH

Richardt, G

Khattab, AA ^{[1
]}

机构：

[1] Univ Kiel, Acad Teaching Hosp, Herzzentrum, Segeberger Klin GmbH, Bad Segeberg, Germany

[2] Univ Klinikum Schleswig Holstein, Med Klin 2, Lubeck, Germany

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2005年 / 96卷 / 05期

关键词：

D O I：

10.1016/j.amjcard.2005.04.044

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this pilot study, we show that periprocedural administration of tirofiban during stenting of critically stenosed saphenous vein grafts, significantly reduces the occurance of postprocedural minor myocardial necroses. (c) 2005 Elsevier Inc. All rights reserved.

引用

收藏

页码：681 / 684

页数：4

相关论文

共 8 条

[1] Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts [J].

Baim, DS ;

Wahr, D ;

George, B ;

Leon, MB ;

Greenberg, J ;

Cutlip, DE ;

Kaya, U ;

Popma, JJ ;

Ho, KKL ;

Kuntz, RE .

CIRCULATION, 2002, 105 (11) :1285-1290

[2]

Heller LI, 1997, CIRCULATION, V96, P484

[3] Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality [J].

Hong, MK ;

Mehran, R ;

Dangas, G ;

Mintz, GS ;

Lansky, AJ ;

Pichard, AD ;

Kent, KM ;

Satler, LF ;

Stone, GW ;

Leon, MB .

CIRCULATION, 1999, 100 (24) :2400-2405

[4] ANGIOGRAPHIC PREDICTORS OF A RISE IN SERUM CREATINE-KINASE (DISTAL EMBOLIZATION) AFTER BALLOON ANGIOPLASTY OF SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS [J].

LIU, MW ;

DOUGLAS, JS ;

LEMBO, NJ ;

KING, SB .

AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (07) :514-517

[5] Applicability of distal protection for aortocoronary vein graft interventions in clinical practice [J].

Mathew, V ;

Lennon, RJ ;

Rihal, CS ;

Bresnahan, JF ;

Holmes, DR .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 63 (02) :148-151

[6] Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts - A pooled analysis of five randomized clinical trials [J].

Roffi, M ;

Mukherjee, D ;

Chew, DP ;

Bhatt, DL ;

Cho, L ;

Robbins, MA ;

Ziada, KM ;

Brennan, DM ;

Ellis, SG ;

Topol, EJ .

CIRCULATION, 2002, 106 (24) :3063-3067

[7] Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts [J].

Stone, GW ;

Rogers, C ;

Hermiller, J ;

Feldman, R ;

Hall, P ;

Haber, R ;

Masud, A ;

Cambier, P ;

Caputo, RP ;

Turco, M ;

Kovach, R ;

Brodie, B ;

Kuntz, RE ;

Popma, JJ ;

Ramee, S ;

Cox, DA .

CIRCULATION, 2003, 108 (05) :548-553

[8] The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty - The ADVANCE trial [J].

Valgimigli, M ;

Percoco, G ;

Barbieri, D ;

Ferrari, F ;

Guardigli, G ;

Parrinello, G ;

Soukhomovskaia, O ;

Ferrari, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (01) :14-19